MX2009008281A - Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. - Google Patents

Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Info

Publication number
MX2009008281A
MX2009008281A MX2009008281A MX2009008281A MX2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A MX 2009008281 A MX2009008281 A MX 2009008281A
Authority
MX
Mexico
Prior art keywords
processes
metal ion
modified poly
preparation
hydroxy metal
Prior art date
Application number
MX2009008281A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan Joseph Powell
Sylvaine Francoise Aline Bruggraber
Nuno Jorge Rodrigues Faria
Dora Isabel Amaral Pereira
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0702270.0A external-priority patent/GB0702270D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Publication of MX2009008281A publication Critical patent/MX2009008281A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/295Iron group metal compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • C07F15/025Iron compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76Metal complexes of amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00Subject matter not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Catalysts (AREA)
  • Cosmetics (AREA)
MX2009008281A 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion. MX2009008281A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88838607P 2007-02-06 2007-02-06
GBGB0702270.0A GB0702270D0 (en) 2007-02-06 2007-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
PCT/GB2008/000408 WO2008096130A1 (en) 2007-02-06 2008-02-06 Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation

Publications (1)

Publication Number Publication Date
MX2009008281A true MX2009008281A (es) 2009-08-25

Family

ID=39204358

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008281A MX2009008281A (es) 2007-02-06 2008-02-06 Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.

Country Status (15)

Country Link
US (1) US8058462B2 (enExample)
EP (1) EP2125847B1 (enExample)
JP (1) JP5756598B2 (enExample)
KR (1) KR101514470B1 (enExample)
AU (1) AU2008212653B2 (enExample)
BR (1) BRPI0807212B1 (enExample)
CA (1) CA2676146C (enExample)
CY (1) CY1116590T1 (enExample)
EA (1) EA019635B1 (enExample)
GB (1) GB2451713B (enExample)
HR (1) HRP20150944T1 (enExample)
IL (1) IL199901A (enExample)
MX (1) MX2009008281A (enExample)
PL (1) PL2125847T3 (enExample)
WO (1) WO2008096130A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0814326D0 (en) * 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses
GB201101299D0 (en) 2011-01-25 2011-03-09 Medical Res Council Oxygen sensors and their uses
GB201507002D0 (en) * 2015-04-24 2015-06-10 Medical Res Council Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
US11267836B2 (en) 2016-03-31 2022-03-08 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides
EP3436442B1 (en) 2016-03-31 2020-10-28 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ferrous hydroxides
SG11201901129XA (en) 2016-08-10 2019-03-28 Res & Innovation Uk Compositions comprising nanosilica particles and their use in methods of activating t lymphocytes for therapy
KR20200044030A (ko) 2017-09-11 2020-04-28 파르마코스모스 홀딩 에이/에스 치료용 철 착화합물
GB202005054D0 (en) * 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
WO2022061065A1 (en) * 2020-09-17 2022-03-24 Doyle Robert P Complexes of magnesium maltol (3-hydroxy-2-methyl-4h-pyran-4-one) for oral supplementation
KR20240041957A (ko) 2021-08-03 2024-04-01 파르마코스모스 홀딩 에이/에스 반려동물의 철 결핍증 치료방법에서 피하 사용을 위한 철 착화합물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL264270A (enExample) *
US2575347A (en) * 1949-07-14 1951-11-20 Interchem Corp Metallo organic compounds
GB959282A (en) * 1959-08-19 1964-05-27 Hardman & Holden Ltd Improvements relating to organic aluminium compounds
US3076798A (en) 1961-02-23 1963-02-05 Hausmann Lab Ltd Process for preparing a ferric hydroxide polymaltose complex
US3679377A (en) 1970-02-17 1972-07-25 Union Oil Co Iron complexes containing aquo,sulfate and hydroxyl ligands
US3821192A (en) 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
US4162986A (en) * 1977-06-20 1979-07-31 Mooney Chemicals, Inc. Oil-soluble high metal content transitional metal organic oxy, hydroxy, complexes
US4137359A (en) 1977-10-31 1979-01-30 Mooney Chemicals, Inc. Elastomers with improved metal adhesion
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
US6177581B1 (en) 1999-10-12 2001-01-23 The Dow Chemical Company Mixed-metal chelates and process for the preparation thereof
US20030049284A1 (en) 2001-09-05 2003-03-13 Boccio Jose Ruben Method of increasing the solubility of alphahydrocarboxilic salts, and products obtained by the method
EP1434869B1 (en) 2001-10-08 2010-12-15 Purac Biochem N.V. Method for preparing calcium gluconate
EP1476399B1 (en) * 2002-01-24 2007-03-28 William Marsh Rice University Organic acid-feooh (ferroxane) particles and ferroxane-derived ceramics and ceramic membranes
US7994217B2 (en) 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
GB0211500D0 (en) 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US6706904B1 (en) 2002-12-04 2004-03-16 Albion International, Inc. Dimetalhydroxy malates
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
EP1733058B8 (en) 2004-03-16 2012-10-24 Navinta LLC Iron sucrose complexes and method of manufacture thereof
WO2005094203A2 (en) 2004-03-16 2005-10-13 Navinta, Llc Sodium ferric gluconate complexes and method of manufacture thereof
BRPI0515847A (pt) 2004-10-08 2008-08-12 Unilever Nv uso de um complexo de ferro, composição alimentìcia, gênero alimentìcio fortificado com ferro, composição de bebida, bebida fortificada com ferro, suplemento alimentar e composição farmacêutica
DE202005014332U1 (de) 2005-09-09 2006-01-19 Institut für Oberflächenmodifizierung e.V. Metallorganisches Nanopulver
GB2451713B (en) 2007-02-06 2009-12-16 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
TWI592159B (zh) 2007-11-16 2017-07-21 威佛(國際)股份有限公司 藥學組成物
GB0814326D0 (en) 2008-08-05 2008-09-10 Medical Res Council Phosphate binding materials and their uses

Also Published As

Publication number Publication date
KR101514470B1 (ko) 2015-04-22
GB0802214D0 (en) 2008-03-12
GB2451713B (en) 2009-12-16
GB2451713A (en) 2009-02-11
US8058462B2 (en) 2011-11-15
EA019635B1 (ru) 2014-05-30
IL199901A0 (en) 2010-04-15
US20080188555A1 (en) 2008-08-07
CY1116590T1 (el) 2017-03-15
CA2676146C (en) 2016-08-09
IL199901A (en) 2014-11-30
PL2125847T3 (pl) 2015-12-31
JP2010520856A (ja) 2010-06-17
BRPI0807212B1 (pt) 2022-01-11
KR20090121281A (ko) 2009-11-25
BRPI0807212A2 (pt) 2014-06-17
HK1138598A1 (en) 2010-08-27
EP2125847A1 (en) 2009-12-02
JP5756598B2 (ja) 2015-07-29
AU2008212653A1 (en) 2008-08-14
AU2008212653B2 (en) 2012-05-24
CA2676146A1 (en) 2008-08-14
HRP20150944T1 (hr) 2015-10-09
EA200970718A1 (ru) 2010-02-26
WO2008096130A1 (en) 2008-08-14
EP2125847B1 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
MX2009008281A (es) Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.
WO2009111159A3 (en) Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
WO2004063342A3 (en) Cellular delivery and activation polypeptide-nucleic acid complexes
IL218317A (en) Use of 15-il polypeptide preparations and 15-il complexes for the preparation of cancer drugs
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
EP2051572A3 (en) Housing for electronic components
EP2145902A3 (en) Tyrosine phosphorylation sites and antibodies specific for them
WO2008140594A3 (en) Peptide nanoparticles and uses therefor
MY154217A (en) Ingestible circuitry
WO2007124302A3 (en) Bone graft composition
WO2010083385A3 (en) Compounds for reducing drug resistance and uses thereof
WO2009149339A3 (en) P53 activator peptides
WO2008104804A3 (en) Proteins
WO2008151022A3 (en) Nucleic acid nanoparticles and uses therefor
WO2007005912A3 (en) Compositions for treating wounds and processes for their preparation
WO2009100716A3 (de) Implantierbare nanopartikel-enthaltende produkte
WO2007098127A3 (en) Compositions for treating wounds and processes for their preparation
PT2153260T (pt) Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma
IL184700A0 (en) Method of providing readily available cellular material derived from cord blood, and composition thereof
AU2007249926A8 (en) Monocyclic heteroaryl compounds
WO2008101692A3 (en) Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
WO2011005510A3 (en) Peptide conjugates and uses thereof
WO2008013954A3 (en) Tyrosine phosphorylation sites
WO2008104528A3 (en) Implantable material comprising cellulose and the glycopeptide xyloglucan-grgds

Legal Events

Date Code Title Description
FG Grant or registration